Current Controversies in Newer Therapies to Treat Birth Asphyxia
Despite major advances in monitoring technology and knowledge of fetal and neonatal pathophysiology, neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the main causes of severe adverse neurological outcome in children. Until recently, there were no therapies other than supportive measure...
Saved in:
Main Author: | Pia Wintermark |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2011/848413 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic Theophyline reduces birth asphyxia related renal injury in term neonates
by: Salma Aziz, et al.
Published: (2023-01-01) -
Water Birth – Benefits, Risks, and Controversies
by: Julia Górny, et al.
Published: (2025-01-01) -
Neonatal Thrombocytopenia after Perinatal Asphyxia Treated with Hypothermia: A Retrospective Case Control Study
by: N. Boutaybi, et al.
Published: (2014-01-01) -
Future Uses of Newer Macrolides
by: John Segreti
Published: (1993-01-01) -
Transient Cholestasis in Newborn Infants with Perinatal Asphyxia
by: D Herzog, et al.
Published: (2003-01-01)